Literature DB >> 22511419

Is high-dose chemotherapy superior to conventional chemotherapy as first salvage treatment for patients with metastatic germ cell tumors?

Bassel G Bachir1, Wassim Kassouf.   

Abstract

Entities:  

Year:  2012        PMID： 22511419      PMCID： PMC3328552          DOI： 10.5489/cuaj.12060

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  15 in total

1.  Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.

Authors:  Anja Lorch; Caroline Bascoul-Mollevi; Andrew Kramar; Lawrence Einhorn; Andrea Necchi; Christophe Massard; Ugo De Giorgi; Aude Fléchon; Kim Margolin; Jean-Pierre Lotz; Jose Ramon Germà-Lluch; Thomas Powles; Christian Kollmannsberger; Jörg Beyer
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

2.  A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.

Authors:  J-L Pico; G Rosti; A Kramar; H Wandt; V Koza; R Salvioni; C Theodore; G Lelli; W Siegert; A Horwich; M Marangolo; W Linkesch; G Pizzocaro; H-J Schmoll; J Bouzy; J-P Droz; P Biron
Journal:  Ann Oncol       Date:  2005-05-31       Impact factor: 32.976

3.  Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.

Authors:  J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; M Mego; M Recková; I Koza
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

4.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

5.  TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Authors:  Darren R Feldman; Joel Sheinfeld; Dean F Bajorin; Patricia Fischer; Stefan Turkula; Nicole Ishill; Sujata Patil; Manjit Bains; Lilian M Reich; George J Bosl; Robert J Motzer
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  Consolidative high-dose chemotherapy after conventional-dose chemotherapy as first salvage treatment for male patients with metastatic germ cell tumours.

Authors:  Michel Beausoleil; D Scott Ernst; Larry Stitt; Eric Winquist
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

Review 7.  Medical treatment of advanced testicular cancer.

Authors:  Darren R Feldman; George J Bosl; Joel Sheinfeld; Robert J Motzer
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

8.  High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.

Authors:  J Beyer; S Stenning; A Gerl; S Fossa; W Siegert
Journal:  Ann Oncol       Date:  2002-04       Impact factor: 32.976

9.  Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.

Authors:  P J Loehrer; R Gonin; C R Nichols; T Weathers; L H Einhorn
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

10.  Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.

Authors:  Darren R Feldman; Robert Huddart; Emma Hall; Jörg Beyer; Thomas Powles
Journal:  J Cancer       Date:  2011-07-01       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.